<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="371032">
  <stage>Registered</stage>
  <submitdate>7/07/2016</submitdate>
  <approvaldate>25/07/2016</approvaldate>
  <actrnumber>ACTRN12616000971437</actrnumber>
  <trial_identification>
    <studytitle>High Frequency Peripheral nerve stimulation for chronic pain</studytitle>
    <scientifictitle>High frequency (HF10) peripheral nerve stimulation (PNS) for chronic neuropathic pain</scientifictitle>
    <utrn />
    <trialacronym>HF10 PNS</trialacronym>
    <secondaryid>Nil Known</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Chronic Neuropathic Pain</healthcondition>
    <conditioncode>
      <conditioncode1>Anaesthesiology</conditioncode1>
      <conditioncode2>Pain management</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Neurological</conditioncode1>
      <conditioncode2>Other neurological disorders</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Musculoskeletal</conditioncode1>
      <conditioncode2>Other muscular and skeletal disorders</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>This study is a clinical audit of patients undergoing implantation of commercially-available and TGA-approved high frequency stimulators  (Nevro high frequency stimulator and electrode leads, TGA certificate DV-2011-MC-00182-3) in the clinical management of pain. Pain ratings, Oswestry Disability ratings, patient satisfaction and morphine equivalent consumption will be assessed before the implant and one year aferwards.</interventions>
    <comparator>No control group</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Not applicable</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>pain ratings on a visual analogue scale</outcome>
      <timepoint>one year post stimulation implantation procedure</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Disability score on the Oswestry Disability Scale</outcome>
      <timepoint>one year post stimulation implantation procedure</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>satisfaction rating on a 1-5 numerical scale</outcome>
      <timepoint>one year post stimulation implantation procedure</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Patients will self-report consumption of opioid drugs at each clinical review. A morphine equivalent consumption score before and one year after the stimulator is implanted will be calculated using the OPIOID CONVERSION to oral MORPHINE EQUIVALENT DAILY DOSE Toolkit http://www.hnehealth.nsw.gov.au/Pain/Documents/FPM_opioid_conversion_20141.pdf</outcome>
      <timepoint>one year post stimulation implantation procedure</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>All patients at Dr Finchs pain practice who were implanted with a high frequency electrical nerve stimulator (Nevro high frequency stimulator and electrode leads, TGA certificate DV-2011-MC-00182-3) between 1st January 2013 and 1st February 2017 will be invited to be included in the clinical audit. </inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage />
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>None</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Observational</studytype>
    <purpose />
    <allocation />
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods>All patients who were implanted with a Nevro high frequency stimulator and electrode leads (TGA certificate DV-2011-MC-00182-3) between 1st January 2013 and 1st February 2017 will be invited to participate in the clinical audit. Analysis of variance will be used to investigate changes from before to after stimulator implantation. </statisticalmethods>
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry>True</patientregistry>
    <followup>1</followup>
    <followuptype>Years</followuptype>
    <purposeobs>Natural history</purposeobs>
    <duration>Longitudinal</duration>
    <selection>Defined population</selection>
    <timing>Both</timing>
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>15/08/2016</anticipatedstartdate>
    <actualstartdate>15/08/2016</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize>65</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <anticipatedlastvisitdate>11/08/2017</anticipatedlastvisitdate>
    <actuallastvisitdate />
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>WA</recruitmentstate>
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>Murdoch University</primarysponsorname>
    <primarysponsoraddress>90 South Street, Murdoch, 6150 WA</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Self funded/Unfunded</fundingtype>
      <fundingname>Dr Philip Finch</fundingname>
      <fundingaddress>Perth Pain Management Centre, 18 Hardy Street, South Perth, 6151 WA</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Individual</sponsortype>
      <sponsorname>Philip Finch</sponsorname>
      <sponsoraddress>Perth Pain Management Centre, 18 Hardy Street, South Perth, 6151 WA</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
    <othercollaborator>
      <othercollaboratortype>Individual</othercollaboratortype>
      <othercollaboratorname>Peter Drummond</othercollaboratorname>
      <othercollaboratoraddress>Murdoch University, 90 South Street Murdoch 6150 WA</othercollaboratoraddress>
      <othercollaboratorcountry>Australia</othercollaboratorcountry>
    </othercollaborator>
  </sponsorship>
  <ethicsAndSummary>
    <summary>This study is a clinical audit of patients undergoing implantation of a commercially-available and TGA-approved high frequency stimulator (TGA certificate DV-2011-MC-00182-3) between 1st January 2013 and 1st February 2017 for the clinical management of pain. The study will be a two-year audit of pain scores, disability index, analgesic drug consumption and patient satisfaction after implantation of a high frequency electrical nerve stimulator. Each patient will provide their informed consent for their data to be included in the clinical audit. </summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Murdoch University Human Research Ethics Committee</ethicname>
      <ethicaddress>90 South Street, Murdoch 6150 WA</ethicaddress>
      <ethicapprovaldate>11/08/2016</ethicapprovaldate>
      <hrec>2016/133</hrec>
      <ethicsubmitdate>5/07/2016</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Dr</title>
      <name>Philip Finch</name>
      <address>Perth Pain Management Centre, 18 Hardy Street, South Perth, 6151 WA</address>
      <phone>+61 8 93672233</phone>
      <fax />
      <email>pfinch@iinet.net.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Philip Finch</name>
      <address>Perth Pain Management Centre, 18 Hardy Street, South Perth, 6151 WA</address>
      <phone>+61 8 93672233</phone>
      <fax />
      <email>pfinch@iinet.net.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Philip Finch</name>
      <address>Perth Pain Management Centre, 18 Hardy Street, South Perth, 6151 WA</address>
      <phone>+61 8 93672233</phone>
      <fax />
      <email>pfinch@iinet.net.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>